Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.

“Follow MedCity News if you want to know who is doing what in healthcare innovation - and whether it's working or not.”

Chris Seper, CEO & Founder, MedCityNews.com

Sign up for our daily newsletter

Forest Laboratories submits Cariprazine drug application

November 28, 2012 2:17 am by | 0 Comments

BUDAPEST (Reuters) - Forest Laboratories has recently submitted a new drug application to the U.S. Food and Drug Administration (FDA) for antipsychotic drug Cariprazine, its Hungarian partner Richter said in a statement on Wednesday.

Cariprazine was discovered by Richter and is licensed to Forest Laboratories Inc. in the U.S. and Canada.

Richter said Forest's application to the FDA was submitted for the treatment of both schizophrenia and manic or mixed episodes associated with bipolar I disorder.

(Reporting by Gergely Szakacs; Editing by David Goodman)


Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.